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Introduction
Over the past few years, some epilepsies have been
found to be associated with immunomediated disorders.
The presence of antibodies against intracellular and
extracellular proteins especially in refractory epilepsy
provides additional evidence of immunomediated dis-
eases in the brain. In refractory epilepsy, autoantibodies
against NMDAR, GAD and the VGKC-complex can be
found in 2 to 16% of patients. The definition of autoin-
flammatory diseases was first introduced by Kastner et
al in 2009 after the discovery of a homozygous mutation
in the gene MEV1, responsible for Mediterranean Fever.
After that, the recognition of inflammassome and inter-
leukin 1 as the main actors in the innate immune sys-
tem responsible for inflammation in these diseases has
changed the treatment for some rare disorders.
Objective
To present the case of a patient that had persistent
pleocytosis in the cerebrospinal fluid and seizures refrac-
tory to current drugs for epilepsy, with clinical improve-
ment with nonspecific imunossupression. To discuss the
aetiology of inflammation in the brain with a review of
the literature.
Methods
Case report and review of the literature with the terms:
“refractory epilepsy”; “chronic encephalitis”; “autoimmune
epilepsy”; “autoinflammation of the brain”; “immunome-
diated brain diseases”; “autoinflammatory disease”
Results
Case report: The patient, A.C.S. female, 19 years old, is
a Brazilian girl, that grew up in São Paulo, from non-
consanguineous and healthy parents. Seizures started at
2 years old characterized as motor arrest during seconds
followed by crying. When she was 13, she dropped after
a spell, seeked medical attention and started medication
for epilepsy. Seizures are controlled and usually hap-
pened during sleep. At 16 years old, seizures increased
and began to happen while she was awake. At this
point, seizures are characterized as motor arrest, right
arm elevation and cephalic version to the left. Despite
the use of innumerous antiepileptic drugs in elevated
dosages, she maintained refractory seizures (weekly).
Extensive complementary epilepsy investigation was per-
formed. Unexpectedly, CSF studies revealed persistent
pleocitosis and/or elevated protein. PET showed marked
hypometabolism in left cerebral hemisphere, specially in
frontal and temporal regions. Head MRI showed inespe-
cific white matter hyperintensities in FLAIR sequences.
A panel of known neural auto-antibodies (NMDA,
GABA, AMPA, VGKC) and anti GAD were negative.
Considering the CSF alterations, the hypothesis of an
immunomediated epilepsy was made and we decided
empirically treat with intravenous high-dose corticoster-
oids (metylprednisolone 5 g monthly for 6 months).
After the second month, she improved dramatically and
had no more seizures. After 6 months, we decided to
keep imunosuppresion with azatioprine with excellent
response (2 focal seizures in 18 months). CSF results
were normal after treatment. Her quality of life and cog-
nition also improved.
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Review of literature
Immunomediated epilepsy is a controversial issue that is
gaining more relevance since the discovery of many
neural autoantibodies related to paraneoplasic/immuno-
mediated encephalitis. Frequently, immunomediated
encephalitis presents with seizures, including status
epilepticus, sometimes refractory. In these disorders, sei-
zures are only controlled after treatment with immu-
notherapy (high dose corticosteroids, gammaglobulin,
etc). A considerable portion of chronic refractory epilep-
sies are of unknown causes. The role of neural autoanti-
bodies in these cases are under investigation. Besides
that, to what extent the damage is caused by the antibo-
dies itself or by the inflamatory reaction in the brain is
also debatable. In this case, despite negative antibodies,
the patient had CSF alterations that could point to a
inflammatory process in the CNS. Based on this hypoth-
esis, we treated with high doses corticosteroids and the
patient had an excellent response. Until this moment, the
only well recognized monogenic autoinflammatory dis-
ease with central nervous involvement are cryopirin-
asociated periodic syndromes (FCAS, Mucke-Wells and
NOMID), mevalonate kinase deficiency (Hyper IgD and
mevalonate aciduria) and mutations in the proteasome
(CANDLE disease). Salsano et al, 2013, reported an adult
patient with chronic meningitis and progressive hearing
loss without evidence of mutations in the IL-1 pathway.
This patient also demonstrated only IL-6 hypersecretion
and clinical improvement with tocilizumab (interleukin 6
blocker). Dutra et al, 2013 also described an adult patient
with CNS involvment and clinical manifestation of CAPS
that were responsive to interleukin 1 blocker (anankira)
with extensive genetic analysis negative.
Conclusion
We propose that this patient, with refractory epilepsy
and CSF chronic inflamation might be a prototype of a
novel category of autoinflammatory disease.
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